Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Avadel Pharmaceuticals Plc (AVDL)

6.7 -0.12 (-1.76%)

05-22 16:00

Open:

6.82

Pre. Close:

6.82

High:

6.95

Low:

6.63

Volume:

543,604

Market Cap:

246M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

6.958 - 7.014

7.014 - 7.052

Low:

6.515 - 6.576

6.576 - 6.617

Close:

6.62 - 6.715

6.715 - 6.778

Technical analysis  (as of: 2018-05-22 4:36:51 PM)

Overall:

      

Stoxline posted a STRONG SELL today, downgraded from higher rating. This stock seems to be very strong for short side. So you may continue to hold the short positions or sell your long positions. You are relatively safe to short or sell as long as the BUY warning is not issued.

Target:

Six months: 8.20     One year: 8.82

Support:

Support1: 6.17    Support2: 5.13

Resistance:

Resistance1: 7.02    Resistance2: 7.55

Pivot:

6.81

Moving Averages:

MA(5): 6.88     MA(20): 6.82

MA(100): 8.14     MA(250): 9.06

MACD:

MACD(12,26): -0.09     Signal(12,26,9): -0.12

%K %D:

%K(14,3): 64.40     %D(3): 70.36

RSI:

RSI(14): 41.71

52-Week:

High: 11.93  Low: 6.17  Change(%): -32.6

Average Vol(K):

3-Month: 49447  10-Days 60905

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
AVDL has closed above bottom band by 31.8%. Bollinger Bands are 69% narrower than normal. The narrow width of the bands suggests low volatility as compared to AVDL's normal range. The bands have been in this narrow range for 38 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2018-05-03T13:33:26-04:00
Avadel Pharmaceuticals plc 2018 Q1 - Results - Earnings Call Slides

2018-05-02T16:32:05-04:00
Avadel Pharmaceuticals' (AVDL) CEO Michael Anderson on Q1 2018 Results - Earnings Call Transcript

2018-05-02T07:32:45-04:00
Avadel Pharmaceuticals beats by $0.03, beats on revenue

2018-04-04T11:27:09-04:00
Avadel Offers An Excellent Risk/Reward Profile

2018-03-16T10:26:29-04:00
Key events next week - healthcare (continued #1)

2018-03-08T17:20:07-05:00
Avadel Pharmaceuticals' (AVDL) CEO Michael Anderson on Q4 2017 Results - Earnings Call Transcript

2018-03-08T13:19:24-05:00
Avadel Pharmaceuticals plc 2017 Q4 - Results - Earnings Call Slides

2018-03-08T08:55:58-05:00
Does Avadel Pharmaceuticals Have The Potential To 10-Double?

Financial Analysis

Growth

NA

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

NA

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

NA

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  0

Industry:  0

Shares Out. (M)

36.75

Shares Float (M)

35.78

% Held by Insiders

2.50

% Held by Institutions

74.20

Shares Short (K)

3773

Shares Short Prior Month (K)

598

Stock Financials

EPS

-0.340

EPS Est. Current Year

1.160

EPS Est. Next Year

0.250

EPS Est. Next Quarter

-0.100

Forward EPS

-0.060

Book Value (p.s.)

2.810

PEG Ratio

-0.64

Profit Margin

19.62

Operating Margin

35.21

Return on Assets (ttm)

9.9

Return on Equity (ttm)

41.2

Qtrly Rev. Growth

-19.3

Gross Profit (p.s.)

2.113

Sales Per Share

EBITDA (p.s.)

1.689

Qtrly Earnings Growth

Operating Cash Flow (M)

16.66

Levered Free Cash Flow (M)

18.09

atoplab.com

Valuation

P/E

-19.71

P/E Growth Ratio

-0.02

P/BV

2.38

P/S

57529204.00

P/CF

14.78

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.